COVID-19 and Aphasia

Curr Neurol Neurosci Rep. 2021 Oct 21;21(11):61. doi: 10.1007/s11910-021-01150-x.

Abstract

Purpose of review: Aphasia is an acquired neurological language disorder after brain damages. Persons with aphasia (PWA) are more susceptible to behavioral and emotional implications due to inherent communication and/or cognitive difficulties. Currently, little is known regarding the impact of COVID-19 on PWA.

Recent findings: There are now growing reports with evidence of neurological and dysexecutive syndromes subsequent to interference of brain functions in acute patients with COVID-19, leading to variable aphasia-like symptoms. COVID-19 affected chronic PWA more in terms of disrupted communication and daily routines, worsened psychosocial well-being, and difficulties getting aphasia services that adequately addressed their needs. Acute versus chronic PWA were disproportionately affected by COVID-19. Recognizing, examining, and managing COVID-19-related neurological and behavioral problems in PWA is not straightforward. As we passed the 1-year mark and approaching the 2-year mark of the onset of COVID-19, more research is necessary to prioritize strategies for improving current evidence-based care and rehabilitation of aphasia.

Keywords: Aphasia; COVID-19.

Publication types

  • Review

MeSH terms

  • Aphasia* / etiology
  • COVID-19*
  • Communication
  • Humans
  • SARS-CoV-2